Paradigm Biopharmaceuticals Ltd (PAR)

Sydney
Currency in AUD
Disclaimer
0.38
-0.01(-1.30%)
Closed
Trading near 52-week Low
Day's Range
0.380.39
52 wk Range
0.381.73
Bid/Ask
0.38 / 0.37
Prev. Close
0.38
Open
0.39
Day's Range
0.38-0.39
52 wk Range
0.38-1.73
Volume
337,669
Average Volume (3m)
1,176,606
1-Year Change
-72.95%
Shares Outstanding
351,495,841
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
2.30
Upside +505.26%
How do you feel today about PAR?
Vote to see community's results!
or

Paradigm Biopharmaceuticals Ltd Company Profile

Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.